Oklahoma 2026 Regular Session

Oklahoma Senate Bill SB1648

Introduced
2/2/26  

Caption

Medicaid; creating the Healthy Moms, Healthy Babies Act; requiring coverage and reimbursement of specified services; requiring certain reimbursement methodology. Effective date.

Impact

The implementation of SB1648 is expected to significantly enhance access to crucial maternal health services for pregnant women enrolled in the Medicaid program. Included in the comprehensive care approach are office visits, laboratory tests, continuous glucose monitoring for gestational diabetes, and the provision of doulas and community health workers for home visits. Additionally, the bill introduces presumptive eligibility determinations, allowing women to begin receiving prenatal care immediately, which is particularly critical for timely intervention in maternal health cases.

Summary

Senate Bill 1648, titled the 'Healthy Moms, Healthy Babies Act', is aimed at improving maternal health outcomes in Oklahoma through the expansion of Medicaid services. The bill mandates that the state Medicaid program cover a range of specified services for pregnant women including depression screening, prenatal, delivery, and postpartum services. Importantly, these services are to be reimbursed separately, ensuring that they are not bundled into global payment methodologies which can obscure the cost and availability of specific maternal health services. This stipulation emphasizes the importance of comprehensive care during the perinatal period.

Contention

While supporters of the bill argue that it addresses gaps in maternal healthcare, enhancing both access and quality of care, there may be potential points of contention regarding the fiscal implications for the state Medicaid budget. The provision for remote monitoring and telehealth services, while innovative, raises questions about the adequacy of infrastructure and reimbursement rates. Furthermore, discussions may emerge about the role of doulas and community health workers, including their qualifications and integration into existing healthcare frameworks. Stakeholders may raise concerns regarding the effective implementation of these services and whether they will translate into improved health outcomes.

Companion Bills

No companion bills found.

Previously Filed As

OK SB1047

Health insurance; requiring reimbursement for certain health care services. Effective date.

OK SB203

Medicaid; requiring the Oklahoma Health Care Authority to provide certain reimbursement to hospitals under specified conditions. Effective date. Emergency.

OK SB226

Medicaid program; providing for certain reimbursement methodology for certain hospitals. Effective date. Emergency.

OK HB2268

Poor persons; terms; Medicaid; reimbursements; effective date.

OK SB1019

Health insurance; requiring certain coverage. Effective date.

OK SB1036

Ambulance service; requiring coverage for certain services. Effective date.

OK SB670

Health care providers; requiring certain continuing education; requiring specified mental health screening. Effective date.

OK SB176

Health benefit plans; requiring coverage for certain prescription. Effective date.

OK SB109

Health insurance; requiring coverage of certain genetic testing and cancer imaging; providing exclusions. Effective date.

OK SB1067

Health insurance; ambulance service provider; providing for establishment of certain database; modifying reimbursement rates and criteria for certain ambulance services. Effective date.

Similar Bills

SC H4305

Wellness reimbursement program

CA AB1429

Behavioral health reimbursement.

TX HB4582

Relating to reimbursement of infrastructure costs incurred by a developer of certain housing developments by certain municipalities and counties.

NV AB511

Revises provisions relating to insurance. (BDR 57-697)

CA AB2640

Commission on State Mandates: state mandates.

AZ HB2447

Insurance; reimbursement rates; nurse anesthetist

CA AB964

Commission on State Mandates: state mandates.

NJ S3165

Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.